EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Escherichia coli Nissle Improves Short-Chain Fatty Acid Absorption and Barrier Function in a Mouse Model for Chronic Inflammatory Diarrhea

Zhenghao Ye iD, Qinghai Tan, Sabrina Woltemate, Xinjie Tan, Dorothee Römermann, Guntram A Grassl, Marius Vital, Ursula Seidler, Archana Kini

Inflammatory Bowel Diseases · 10.04.2025 · 31 (4) · 1109-1120

DOI: 10.1093/ibd/izae294 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, online erschienen am 21.12.2024. Verfasst von Zhenghao Ye und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany. Hauptthemen laut MEDLINE: Fatty Acids, Volatile, Escherichia coli, Diarrhea, Intestinal Mucosa. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Deutsche Forschungsgemeinschaft (DFG), China Scholarship Council (CSC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Defects in SLC26A3, the major colonic Cl−/HCO3− exchanger, result in chloride-rich diarrhea, a reduction in short-chain fatty acid (SCFA)-producing bacteria, and a high incidence of inflammatory bowel disease in humans and in mice. Slc26a3−/− mice are, therefore, an interesting animal model for spontaneous but mild colonic inflammation and for testing strategies to reverse or prevent the inflammation. This study investigates the effect of Escherichia coli Nissle (EcN) application on the microbiome, SCFA production, barrier integrity, and mucosal inflammation in slc26a3−/− mice.

Methods

In vivo fluid absorption and bicarbonate secretion were assessed in the gut of slc26a3+/+ and slc26a3−/− mice before and during luminal perfusion with 100 mM sodium acetate. Age-matched slc26a3+/+ and slc26a3−/− mice were intragastrically gavaged twice daily with 2 × 108 CFU/100 µL of EcN for 21 days. Body weight and stool water content were assessed daily, and stool and tissues were collected for further analysis.

Results

Addition of sodium acetate to the lumen of the proximal colon significantly increased fluid absorption and luminal alkalinization in the slc26a3−/− mice. Gavage with EcN resulted in a significant increase in SCFA levels and the expression of SCFA transporters in the slc26a3−/− cecum, the predominant habitat of EcN in mice. This was accompanied by an increase in mucus-producing goblet cells and a decrease in the expression of inflammatory markers as well as host defense antimicrobial peptides. EcN did not improve the overall diversity of the luminal microbiome but resulted in a significant increase in SCFA producers Lachnospiraceae and Ruminococcaceae in the slc26a3−/− feces.

Conclusions

These findings suggest that EcN is able to proliferate in the inflamed cecum, resulting in increased microbial SCFA production, decreased inflammation, and improved gut barrier properties. In sufficient dosage, probiotics may thus be an effective anti-inflammatory strategy in the diseased gut.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fatty Acids, VolatileEscherichia coliDiarrheaIntestinal MucosaAnimalsMiceDisease Models, AnimalSulfate TransportersGastrointestinal MicrobiomeMice, KnockoutChloride-Bicarbonate AntiportersIntestinal AbsorptionChronic DiseaseColonInflammationMice, Inbred C57BLMaleAntiporters

Stichwörter der Autor:innen

antimicrobial peptideschloride-losing diarrheainflammatory bowel diseaseintestinal microbiomemucus secretionshort-chain fatty acids

Substanzen

Fatty Acids, VolatileSulfate TransportersSlc26a3 protein, mouseChloride-Bicarbonate AntiportersAntiporters

Autor:innen und Institutionen

  • Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany.
  • Department of Gastroenterology, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China.
  • Institute for Medical Microbiology and Hospital Epidemiology, Hannover Medical School, Hannover, Germany.
  • Department of Gastroenterology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • German Centre for Infection Research DZIF, Partner Site Hannover-Braunschweig, Braunschweig, Germany.

ORCID-Profile: Zhenghao Ye

Förderung

  • Deutsche Forschungsgemeinschaft (DFG)
  • China Scholarship Council (CSC)

Zitieren

APA

Ye, Z., Tan, Q., Woltemate, S., Tan, X., Römermann, D., Grassl, G. A., Vital, M., Seidler, U., & Kini, A. (2025). Escherichia coli Nissle Improves Short-Chain Fatty Acid Absorption and Barrier Function in a Mouse Model for Chronic Inflammatory Diarrhea. Inflammatory Bowel Diseases, 31(4), 1109-1120. https://doi.org/10.1093/ibd/izae294

Vancouver

Ye Z, Tan Q, Woltemate S, Tan X, Römermann D, Grassl GA, et al. Escherichia coli Nissle Improves Short-Chain Fatty Acid Absorption and Barrier Function in a Mouse Model for Chronic Inflammatory Diarrhea. Inflammatory Bowel Diseases. 2025;31(4):1109-1120. doi:10.1093/ibd/izae294

BibTeX
@article{Ye2025,
  author = {Ye, Zhenghao and Tan, Qinghai and Woltemate, Sabrina and Tan, Xinjie and Römermann, Dorothee and Grassl, Guntram A and Vital, Marius and Seidler, Ursula and Kini, Archana},
  title = {Escherichia coli Nissle Improves Short-Chain Fatty Acid Absorption and Barrier Function in a Mouse Model for Chronic Inflammatory Diarrhea},
  journal = {Inflammatory Bowel Diseases},
  year = {2025},
  volume = {31},
  number = {4},
  pages = {1109--1120},
  doi = {10.1093/ibd/izae294}
}
Kostenlos starten →